睡眠障碍与炎症对阿尔茨海默病痴呆的影响
本文综述了睡眠障碍与阿尔茨海默病痴呆之间的关系。近半数60岁以上成人报告睡眠障碍,睡眠障碍可能通过增加β-淀粉样蛋白负荷促进认知下降并增加阿尔茨海默病痴呆风险,而系统性炎症可能是其中的早期环节。睡眠与阿尔茨海默病存在双向关系,两者均为可干预的风险因素。
要点
- 睡眠障碍可能通过增加β-淀粉样蛋白负荷增加阿尔茨海默病痴呆风险。
- 睡眠障碍诱导的系统性炎症可能是阿尔茨海默病病程的早期事件。
- 睡眠障碍与炎症激活均为可干预的阿尔茨海默病风险因素。
核心结论
- 睡眠障碍可能通过炎症和β-淀粉样蛋白途径增加阿尔茨海默病痴呆风险,且与阿尔茨海默病存在双向关系。
研究设计与样本
- 本文为综述,检索范围未在摘要中明确报告。
主要发现
- 近半数60岁以上成人报告睡眠障碍,表现为失眠主诉伴日间后果、对睡眠质量或数量不满或失眠障碍诊断。
- 累积证据显示睡眠障碍促进认知下降,并可能通过增加β-淀粉样蛋白负荷增加阿尔茨海默病痴呆风险。
- 睡眠障碍诱导的系统性炎症增加β-淀粉样蛋白负荷,被认为是阿尔茨海默病发病机制的驱动因素。
临床怎么用
- 睡眠障碍和炎症激活是可干预的阿尔茨海默病风险因素,识别相关机制有助于预防靶点的发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nearly half of all adults older than 60 years of age report sleep disturbance, as characterised either by reports of insomnia complaints with daytime consequences, dissatisfaction with sleep quality or quantity, or the diagnosis of insomnia disorder. Accumulating evidence shows that sleep disturbance contributes to cognitive decline and might also increase the risk of Alzheimer's disease dementia by increasing β-amyloid burden. That sleep disturbance would be a candidate risk factor for Alzheimer's disease might seem surprising, given that disturbed sleep is usually considered a consequence of Alzheimer's disease. However, a bidirectional relationship between sleep and Alzheimer's disease is supported by advances in our understanding of sleep disturbance-induced increases in systemic inflammation, which can be viewed as an early event in the course of Alzheimer's disease. Inflammation increases β-amyloid burden and is thought to drive Alzheimer's disease pathogenesis. Improved understanding of the mechanisms linking sleep disturbance and Alzheimer's disease risk could facilitate the identification of targets for prevention, given that both sleep disturbance and inflammatory activation might be modifiable risk factors for Alzheimer's disease.
引用
- Irwin MR, Vitiello MV. Implications of sleep disturbance and inflammation for Alzheimer's disease dementia. Lancet Neurol. 2019. PMID: 30661858. doi:10.1016/S1474-4422(18)30450-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。